Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Filings indexed 1,398 across all filing types
Latest filing 2013-01-03 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Goldman Sachs Healthcare CEOs Unscripted - A view from the Top: - Präsentation
Investor Presentation Classification · 98% confidence The document is titled "Goldman Sachs Healthcare CEOs Unscripted: A view from the Top" and dated January 3, 2013. It contains detailed financial performance metrics (Sales, EBIT, Net Income), segment updates (Fresenius Kabi, Helios, Vamed), financial outlooks, and a full Profit and Loss Statement attachment. This structure, focusing on summarizing recent performance and providing forward guidance in a presentation format, strongly indicates an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a brief earnings release (ER) given its length and depth. It is a comprehensive presentation designed for investors.
2013-01-03 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is a 'Total Voting Rights Announcement' and references Article 26a of the WpHG (German Securities Trading Act). It reports the total number of voting rights as of December 31, 2012. This type of announcement, which reports on the total number of shares or voting rights outstanding, does not fit neatly into the primary categories like 10-K, ER, or IR. It is a specific regulatory disclosure regarding capital structure/shareholder rights. Since there is no specific code for 'Total Voting Rights Announcement,' and it is a regulatory disclosure, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a mandatory, periodic regulatory update that doesn't fit the other specific definitions (like DVA, which is for *results* of a vote, not the total rights count). Given the short length and regulatory nature, RNS is the best fit among the provided options.
2012-12-31 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managerial role ("Member of a managing body"). The content describes the exercise of stock options and subsequent sale of shares by Dr. Ulf M. Schneider, which falls directly under the definition of insider trading or director transactions. This matches the definition for 'Director's Dealing' (DIRS). The document length is short, but the content is the actual filing data, not an announcement of a filing.
2012-12-04 English
Release according to Article 26a, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is a 'Total Voting Rights Announcement according to Article 26a of the WpHG'. This type of announcement relates to the total number of shares with voting rights, which is a specific regulatory disclosure concerning shareholder rights and capital structure, often released monthly or following capital changes. Among the provided definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most fitting category, as it covers announcements related to voting rights, even if this specific one is a periodic total count rather than the result of a specific vote. Given the short length and the nature of the announcement (a simple disclosure of a total number), it fits the regulatory disclosure nature better than a general RNS.
2012-11-30 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction made by a person in a managerial position ("Position: Member of an administrative or supervisory body"). The content describes the exercise of stock options and sale of shares by an executive (Gerd Krick) of Fresenius SE & Co. KGaA. This directly matches the definition for Director's Dealing (DIRS). The presence of the German regulatory reference (section 15a of the WpHG) further confirms this is a mandatory disclosure regarding insider transactions.
2012-11-29 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details transactions made by a person in a managing body ('Rainer Baule'). It specifies the type of transaction as 'Exercise of stock options against cash settlement' for 'Fresenius SE & Co. KGaA Ordinary Share'. This content directly matches the definition for Director's Dealing reports.
2012-11-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.